Search hospitals > Tennessee > Nashville
Sarah Cannon Research Institute
Claim this profileNashville, Tennessee 37203
Global Leader in Uterine Tumors
Global Leader in Solid Tumors
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
670 reported clinical trials
29 medical researchers
Summary
Sarah Cannon Research Institute is a medical facility located in Nashville, Tennessee. This center is recognized for care of Uterine Tumors, Solid Tumors, Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer and other specialties. Sarah Cannon Research Institute is involved with conducting 670 clinical trials across 341 conditions. There are 29 research doctors associated with this hospital, such as Melissa Johnson, MD, Erika P Hamilton, Meredith A McKean, and Vivek Subbiah.Area of expertise
1Uterine Tumors
Global LeaderStage IV
Stage III
HER2 negative
2Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
Top PIs
Melissa Johnson, MDSarah Cannon Research Institute6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
66 reported clinical trials
94 drugs studied
Erika P HamiltonSarah Cannon Research Institute5 years of reported clinical research
Expert in Breast Cancer
Expert in Ovarian Cancer
55 reported clinical trials
77 drugs studied
Meredith A McKeanSarah Cannon Research Institute1 year of reported clinical research
Expert in Solid Tumors
Expert in Uterine Tumors
35 reported clinical trials
67 drugs studied
Vivek SubbiahMD Anderson Cancer Center3 years of reported clinical research
Expert in Solid Tumors
Expert in Uterine Tumors
32 reported clinical trials
47 drugs studied
Clinical Trials running at Sarah Cannon Research Institute
Breast Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Ovarian Cancer
Lung Cancer
Uterine Tumors
Skin Cancer
Endometrial Cancer
Stomach Cancer
Colorectal Cancer
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Zanidatamab vs Trastuzumab
for Breast Cancer
The efficacy and safety of zanidatamab in combination with physician's choice of chemotherapy compared with trastuzumab in combination with physician's choice of chemotherapy will be evaluated for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previous T-DXd treatment.
Recruiting2 awards Phase 34 criteria
PF-07220060
for Solid Cancers
This trial tests a new drug, PF-07220060, in patients with metastatic breast cancer. It aims to find the best dose and see if the drug helps stop cancer growth when used alone or with other treatments.
Recruiting1 award Phase 113 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sarah Cannon Research Institute?
Sarah Cannon Research Institute is a medical facility located in Nashville, Tennessee. This center is recognized for care of Uterine Tumors, Solid Tumors, Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer and other specialties. Sarah Cannon Research Institute is involved with conducting 670 clinical trials across 341 conditions. There are 29 research doctors associated with this hospital, such as Melissa Johnson, MD, Erika P Hamilton, Meredith A McKean, and Vivek Subbiah.
Where is Sarah Cannon Research Institute located?
The Sarah Cannon Research Institute is located at 1100 Dr Martin L King Jr Blvd Ste 800, Nashville, TN. For driving directions, please use 250 25th Ave North, Nashville, TN as your destination.
Who should I call to ask about financial aid or insurance network?
For patient inquiries, contact the Sarah Cannon Research Institute at 615-342-1000. For specific financial concerns, reach out to Patient Account Services at 615-886-4733. The "askSARAH" service on their website also addresses frequently asked questions, including financial assistance topics.
What insurance does Sarah Cannon Research Institute accept?
Sarah Cannon Research Institute is a premier oncology research organization within HCA Healthcare. HCA Healthcare hospitals, including those affiliated with Sarah Cannon, accept most major health insurance plans in the Kansas City area. It is crucial to confirm that both the specific facility and your doctor accept your insurance plan before your visit.
What awards or recognition has Sarah Cannon Research Institute received?
Sarah Cannon Research Institute (SCRI) in Nashville, Tennessee, is a recognized strategic site and was named Clinical Trial Participation Award Recipient in 2015. SCRI has conducted over 600 first-in-human clinical trials. It has contributed to the majority of new cancer therapies approved by the FDA since its inception.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.